Table 4.
Comparisons of glycemic control and lipid profile variables within the control group.
| Variables | Preintervention | Postintervention | T/Z | P value |
|---|---|---|---|---|
| Weight (kg) | 66.05 ± 11.92 | 67.02 ± 11.86 | -1.962 | 0.061 |
| BMI (kg/m2) | 24.45 ± 3.16 | 24.82 ± 3.21 | -2.060 | 0.050 |
| WC (cm) | 87.20 ± 9.56 | 89.00 ± 10.59 | -1.366 | 0.185 |
| HC (cm) | 93.74 ± 6.53 | 97.50 ± 7.38 | -2.871 | 0.008∗ |
| SBP (mmHg) | 145.35 ± 18.71 | 149.87 ± 23.81 | -1.247 | 0.226 |
| DBP (mmHg) | 83.74 ± 9.08 | 85.57 ± 15.76 | -0.691 | 0.497 |
| TC (mmol/L) | 4.41 ± 1.03 | 4.67 ± 0.97 | -2.053 | 0.051 |
| TG (mmol/L) | 1.94 ± 1.22 | 1.63 ± 0.83 | 1.387 | 0.178 |
| HDL-c (mmol/L) | 1.22 ± 0.41 | 1.39 ± 0.37 | -3.638 | 0.001∗ |
| LDL-c (mmol/L) | 2.68 ± 0.99 | 2.94 ± 0.84 | -2.239 | 0.035∗ |
| FPG (mmol/L) | 8.48 ± 3.28 | 7.59 ± 2.82 | 1.721 | 0.098 |
| 2hPG (mmol/L) | 12.25 ± 3.72 | 12.77 ± 4.21 | -0.688 | 0.499 |
| HbA1c (%) | 7.92 ± 2.54 | 7.31 ± 1.58 | 1.985 | 0.059 |
| 1,5-AG (μg/mL) | 89.33 ± 40.20 | 110.97 ± 34.41 | -2.217 | 0.037∗ |
| CV-FPG (%) | 0.20 ± 0.12 | 0.16 ± 0.88 | 1.024 | 0.313 |
| LAGE (mmol/L) | 5.96 ± 2.16 | 6.40 ± 3.08 | -0.445 | 0.662 |
Data are shown as mean ± SD, ∗P < 0.05 for baseline vs. after 6-month within-group.